These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6774433)

  • 1. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
    Guisasola JA; Cockburn CG; Hardisty RM
    Thromb Haemost; 1978 Oct; 40(2):302-15. PubMed ID: 153594
    [No Abstract]   [Full Text] [Related]  

  • 3. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 4. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen.
    Santoro SA
    Biochim Biophys Acta; 1983 Mar; 756(1):123-6. PubMed ID: 6402037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.
    Moake JL; Weinstein MJ; Troll JH; Chute LE; Colannino NM
    Blood; 1983 Jun; 61(6):1163-73. PubMed ID: 6404328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Biol Chem; 1980 Nov; 255(21):10134-9. PubMed ID: 6776109
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding of purified factor VIII/von Willebrand factor to collagens of differing type and form.
    Scott DM; Griffin B; Pepper DS; Barnes MJ
    Thromb Res; 1981 Dec 1-15; 24(5-6):467-72. PubMed ID: 6806932
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.
    Stibbe J
    Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of exercise on the factor VIII complex: a correlation of the Von Willebrand antigen and factor VIII coagulant antigen increase.
    Brown JE; Baugh RF; Hougie C
    Thromb Res; 1979; 15(1-2):61-7. PubMed ID: 314688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies of bovine platelet aggregating factor (PAF).
    Santos F; Wagner RH
    Thromb Res; 1979; 16(3-4):485-96. PubMed ID: 117566
    [No Abstract]   [Full Text] [Related]  

  • 13. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens.
    Santoro SA
    Thromb Res; 1981 Mar; 21(6):689-91. PubMed ID: 6791300
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets.
    Zucker MB; McPherson J; Kim SJ; Macdonald VE; Taylor D; Johnson AJ; Barlow GH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582. PubMed ID: 1081748
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactions of thrombin with human factor VIII/von Willebrande factor protein.
    Switzer ME; McKee PA
    J Biol Chem; 1980 Nov; 255(22):10606-11. PubMed ID: 6776120
    [No Abstract]   [Full Text] [Related]  

  • 16. Dispersity of human factor VIII--Von Willebrand factor.
    van Mourik JA; Bolhuis PA
    Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles.
    Andersson LO; Brown JE
    Biochem J; 1981 Oct; 200(1):161-7. PubMed ID: 6800356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of factor VIII-related von Willebrand factor proteins prepared from human cryoprecipitate and factor VIII concentrate.
    Weinstein M; Deykin D
    Blood; 1979 Jun; 53(6):1095-105. PubMed ID: 312667
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of platelet shape and membrane receptor binding by Ca2+-calmodulin complex.
    Kao KJ; Sommer JR; Pizzo SV
    Nature; 1981 Jul; 292(5818):82-4. PubMed ID: 6268985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.